Recommended diet decreased f-BA in all subjects regardless of the PNPLA3 genotype (Table 3), and f-BA did not correlate with clinical characteristics, diabetes indices (our study subjects were non-diabetic) or NAFLD-related scores (Table S2A). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.